• Deutsch
    • English
  • English 
    • Deutsch
    • English
  • Login
Item View 
  •   Home
  • Medizin
  • Molekulare Medizin
  • Item View
  •   Home
  • Medizin
  • Molekulare Medizin
  • Item View
JavaScript is disabled for your browser. Some features of this site may not work without it.

Cardiac and fibroblastic properties after HIF-1α stabilization

Cardiac and fibroblastic properties after HIF-1α stabilization

by Melanie Vogler
Cumulative thesis
Date of Examination:2015-05-21
Date of issue:2015-06-01
Advisor:Prof. Dr. Dörthe Katschinski
Referee:Prof. Dr. Susanne Lutz
Referee:Prof. Dr. Jörg Großhans
Referee:Prof. Dr. Hubertus Jarry
Referee:Prof. Dr. Jürgen Brockmöller
Referee:PD Dr. Kaomei Guan-Schmidt
crossref-logoPersistent Address: http://dx.doi.org/10.53846/goediss-5108

 

 

Files in this item

Name:Doctoral Thesis Melanie Vogler.pdf
Size:12.4Mb
Format:PDF
ViewOpen

The following license files are associated with this item:


Abstract

English

The cellular oxygen sensing prolyl-4-hydroxylase domain proteins (PHDs) are essential regulators of the α-subunit of hypoxia-inducible transcription factors (HIFs) which are known to induce a variety of genes affecting cell survival, metabolism and angiogenesis. It was shown by the Institute of Cardiovascular Physiology, University Medical Center Göttingen, that stabilization of HIF-1α in cardiomyocyte-specific PHD2 knock out mice results in a tissue protective effect in acute myocardial infarction (MI) (Hölscher et al., 2011). Thus, pharmaceutical stabilization of HIF-1α with small molecule PHD inhibitors could be a suitable approach to induce cytoprotection in case of ischemia. Besides cardiomyocytes, fibroblasts are essentially involved in the organisation of the myocardium as well as in postischemic remodeling. In order to develop new cardio-protective therapeutic strategies, there is a strong need to further define fibroblast-specific functions in hypoxia and the role of HIF-1α in fibroblastic properties. Therefore, the aims of this thesis were (i) to evaluate the effect of a pharmaceutical PHD inhibition using the isoquinoline analog 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) acetate (ICA) for its applicability and protective properties in the heart, (ii) to analyze the role of PHD2 in cardiac fibroblasts via an inducible fibroblast-specific PHD2 knock out mouse, as well as (iii) to examine the morphological and functional responses of fibroblasts to hypoxia in vitro. I could show that L929 fibroblasts respond to hypoxia with striking morphological changes including an enlargement of cell area and volume, increased focal contact assembly and a dramatic reorganization of the actin cytoskeleton with prominent β-actin enriched circular stress fibers. These hypoxic adaptions are associated with enhanced cell spreading as well as reduction in migration properties. Furthermore, it could be shown that the maintenance of p-cofilin levels is dependent on HIF-1α which subsequently affects the actin filament arrangement and may cause the observed increase in cell area and reduction in migration under hypoxic conditions. To study the role of HIF-1α in fibroblastic properties in vivo a tamoxifen-inducible fibroblast-specific PHD2 knock out mouse was generated and Cre-mediated DNA recombination of Phd2 loxP sites could be detected, but lacks PHD2 knock out efficacy on mRNA and protein level. I could show that the PHD inhibitor ICA leads to a rapid and strong HIF-1α and HIF-2α accumulation in the heart and to the induction of HIF target genes which subsequently exert acute cardio-protective effects in MI. ICA treatment significantly reduced total infarct size after MI. This effect was seen not only after pre-conditional treatment, but also after post-conditional application of ICA. This indicates that there is a therapeutic time window for the treatment of ischemic diseases with systemic PHD inhibitors as a useful tool for clinical approaches. Summing up, I could show that hypoxia and specifically HIF-1α greatly affects fibroblastic properties and functions and that a transient HIF-1α stabilization via small molecule PHD inhibitors is a suitable approach to induce cytoprotection in case of ischemia.
Keywords: Hypoxia; HIF; PHD; ICA; MI
 

Statistik

Publish here

Browse

All of eDissFaculties & ProgramsIssue DateAuthorAdvisor & RefereeAdvisorRefereeTitlesTypeThis FacultyIssue DateAuthorAdvisor & RefereeAdvisorRefereeTitlesType

Help & Info

Publishing on eDissPDF GuideTerms of ContractFAQ

Contact Us | Impressum | Cookie Consents | Data Protection Information
eDiss Office - SUB Göttingen (Central Library)
Platz der Göttinger Sieben 1
Mo - Fr 10:00 – 12:00 h


Tel.: +49 (0)551 39-27809 (general inquiries)
Tel.: +49 (0)551 39-28655 (open access/parallel publications)
ediss_AT_sub.uni-goettingen.de
[Please replace "_AT_" with the "@" sign when using our email adresses.]
Göttingen State and University Library | Göttingen University
Medicine Library (Doctoral candidates of medicine only)
Robert-Koch-Str. 40
Mon – Fri 8:00 – 24:00 h
Sat - Sun 8:00 – 22:00 h
Holidays 10:00 – 20:00 h
Tel.: +49 551 39-8395 (general inquiries)
Tel.: +49 (0)551 39-28655 (open access/parallel publications)
bbmed_AT_sub.uni-goettingen.de
[Please replace "_AT_" with the "@" sign when using our email adresses.]